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Strengths and limitations of this study
 ► This review covers a wide variety of the literature 
from a range of different clinical areas.
 ► Data collected and the methods of collecting data 
on the impact of isolation is varied across studies.
 ► These data do not show if these effects are tempo-
rary, or in most cases if they are clinically significant.
AbStrACt
Objective To systematically review the literature exploring 
the impact of isolation on hospitalised patients who are 
infectious: psychological and non- psychological outcomes.
Design Systematic review with meta- analysis.
Data sources Embase, Medline and PsycINFO were 
searched from inception until December 2018. Reference 
lists and Google Scholar were also handsearched.
results Twenty- six papers published from database 
inception to December 2018 were reviewed. A wide 
range of psychological and non- psychological outcomes 
were reported. There was a marked trend for isolated 
patients to exhibit higher levels of depression, the pooled 
standardised mean difference being 1.28 (95% CI 0.47 
to 2.09) and anxiety 1.45 (95% CI 0.56 to 2.34), although 
both had high levels of heterogeneity, and worse outcomes 
for a range of care- related factors but with significant 
variation.
Conclusion The review indicates that isolation to contain 
the risk of infection has negative consequences for 
segregated patients. Although strength of the evidence 
is weak, comprising primarily single- centre convenience 
samples, consistency of the effects may strengthen 
this conclusion. More research needs to be undertaken 
to examine this relationship and develop and test 
interventions to reduce the negative effects of isolation.
IntrODuCtIOn
Isolation is an established part of any infec-
tion prevention programme. Its purpose is to 
prevent the transmission of antibiotic- resistant 
pathogens, those that are highly contagious 
or cause serious infection.1 The effectiveness 
of isolation has been questioned however2–5 
and it can be challenging to undertake, espe-
cially if patients’ lack of understanding of the 
need for segregation, boredom or distress 
result in uncooperative behaviour.6 A recent 
survey exploring the care of patients isolated 
for infectious conditions suggests that in clin-
ical practice the main issues are identifying 
which patients need to be isolated as quickly 
as possible and prioritising which patients 
should be segregated when isolation accom-
modation is in short supply. Infection preven-
tionists were aware that isolation could have 
negative effects on patients, such as increased 
risk of anxiety, depression and falls, and felt 
that more should be done to prevent these 
risks.6
Although single rooms are assumed to 
reduce infection risk, the evidence of ability 
to contain spread is equivocal7 8 and a recent 
study conducted in an all- single- room hospital 
was unable to demonstrate lower infection 
rates than in hospitals where most care takes 
place in open wards.9 This study identified 
the advantages and disadvantages of a single- 
room accommodation, whereas isolating 
infectious patients is generally assumed to 
result in adverse outcomes.10
A systematic review, reported 8 years ago, 
indicated higher levels of anxiety, depres-
sion, perceptions of stigmatisation and a 
higher incidence of falls, medication errors 
and other incidents that detract from patient 
safety among the patients who were isolated 
compared with those who were not.11 This 
review reported studies undertaken before 
2010 and included patients whose experi-
ences are unlikely to be comparable: chil-
dren and adults and those isolated to reduce 
their own risk of infection as well as infec-
tious patients. The review was not reported 
according to standards currently expected 
for systematic reviews12 and presents a qual-
itative description of patient outcomes only. 
A more rigorously reported and up- to- date 
systematic review is indicated in view of 
increasing concern about satisfaction with 
healthcare and patient safety and increasing 
emphasis on infection prevention as part 
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of the global strategy to reduce risks of antimicrobial 
resistance.13
We undertook a systematic review of the literature 
to establish the effects of infection related isolation 
on psychological and non- psychological care- related 
outcomes in adults. This review is therefore more focused 
than previously undertaken, which also included those 
in protective isolation, and contains a significant body of 
literature published since 2010.
MethOD
The eligibility criteria for inclusion was that studies should 
compare quantitative data on psychological or non- 
psychological outcomes in adult patients who are in infec-
tive isolation with those not isolated. Purely symptomatic/
disease progression outcomes were not included, neither 
were those looking at patients isolated due to immunosup-
pression. Studies not containing comparative data between 
those isolated and not isolated were also excluded. Search 
terms were: Patient isolation; cross infection; contact 
isolation; respiratory, source or contact isolation; droplet, 
airborne or contact precautions; cubicle; methicillin- 
resistant Staphylococcus aureus (MRSA); patient safety or 
harm; depression; anxiety; adaptation; stress; patient satis-
faction; quality of life. These were searched as free- text 
and index terms where these existed. The information 
sources used were Embase, Medline and PsycINFO, which 
were searched from inception to December 2018. The full 
Medline search is shown in online supplementary file 1. 
Reference lists and Google Scholar were also handsearched. 
The characteristics of included and excluded papers 
are shown in online supplementary file 2. The Preferred 
Reporting Items for Systematic Reviews and Meta- Analyses 
(PRISMA) flow chart is given in online supplementary file 
3. No protocol was published in advance.
The studies were initially screened for relevance by one 
author (EP), with the final stage being undertaken by two 
(EP and DG). Data were extracted and checked by two 
authors (DG and EP); where there were disagreements 
data were rechecked for relevance and accuracy. Where 
available, raw data were extracted and entered into a 
spreadsheet, and depending on the nature of the data 
either the risk ratio (RR) (where numbers of patients 
were given) or standardised mean difference (where 
other statistics were given) calculated. The results were 
then presented as forest plots.
Due to the variety of different settings and methods, 
it was deemed that the methodological and clinical 
heterogeneity was too broad to pool results; apart from 
those related to anxiety and depression, for which 
results were pooled using the random- effects model. 
This model assumes that the observed effect from each 
study is estimating a related but different true effect, 
allowing for between- study variation to be calculated in 
the form of heterogeneity statistics. All calculations and 
plots were produced using the meta and metafor pack-
ages in R.14–16 Where raw data were not provided, and 
the summary results are given in the text but not the 
forest plots. All data relevant to the study are included 
in the article or uploaded as online supplementary file 
 4. 
Patient and public involvement
No patient involved.
reSultS
A total of 3879 papers were retrieved from the three data-
bases; of which, 38 were assessed for eligibility by reading 
the full text. Of these, 13 studies provided data suitable 
for the calculation of risk ratio (RR), 5 giving psycho-
logical outcomes17–21 and 12 non- psychological19 22–32; 
and 8 provided data for the calculation of standardised 
mean differences (SMD), 6 giving psychological 
outcomes21 30 33–36 and 2 non- psychological.29 37 Further 
six studies did not provide raw data but are included in 
the results; three each giving psychological outcomes38–40 
and non- psychological outcomes.17 41 42 Meta- analyses 
were possible on two outcomes: anxiety and depression 
from eight studies by using standardised mean differ-
ence.19–21 30 33–36 Where only RR data were given20 21 conver-
sion to standardised mean difference was undertaken 
using the Campbell Collaboration calculator (https:// 
camp bell coll abor ation. org/ research- resources/ effect- 
size- calculator. html).43
Where it was not possible to pool outcome data because 
of methodological and clinical heterogeneity, the data 
from studies are shown as forest plots but without meta- 
analysis. The forest plots contain results from the studies 
where sufficient data were given to calculate either the 
RR or standardised mean difference. A number of studies 
provided data on those under contact precautions, but no 
comparative data and so were not included.44–47
Because of the large number of non- psychological 
outcomes for which RR could be calculated, it was decided 
that a change of 20% (ie, an RR of 0.8 or less, or 1.2 or 
more) would be clinically significant, regardless of the 
statistical significance. This was a pragmatic decision, and 
all results are shown in online supplementary file 4. The 
results are shown in figures 1–6. Online supplementary 
file 5 contains the results that did not meet our criteria 
for being clinically significant. Outcomes were classified 
into one of three categories: those to do with quality of 
care; satisfaction of care; and adverse events from which 
median values and interquartile ranges were calculated.
The studies included were primarily single- centre and 
consisted of case–control, cross- sectional and cohort 
studies. The risk of bias was assessed by using the Newcastle- 
Ottowa scale, full details of each study and its risk of 
bias are in the online supplementary file 6.48 Overall, 
although these studies have limited generalisability, 
there did not appear to be significant cause for concern 
regarding bias within the limitations inherent in these 
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Figure 1 Risk ratio (RR) of psychological events in those isolated versus not isolated.
Figure 2 Standardised mean difference of psychological scores in those isolated versus those not isolated.
study designs. Most studies used established or validated 
tools17–21 23–25 27 29 30 33–37 or clinical outcomes.22 26 28 31 32
The data from the comparative studies suggest that 
although in many cases infective isolation precautions 
make little difference to psychological outcomes, where 
it does make a difference this is primarily negative. 
There were significant declines in mean scores related 
to control and self- esteem, and in many studies increases 
in the mean scores for risk of anxiety and depression. 
However, these findings were not consistent, and some 
larger studies showed little or no difference between the 
groups for these outcomes. These are shown in figures 1 
and 2, respectively.
For the eight studies reporting data on anxiety, the 
pooled SMD was 1.45 (95% CI 0.56 to 2.34); although 
within this there was significant heterogeneity (Q=168.11, 
df=7, p<0.0001; I2=95.84%). This was primarily caused by 
two studies30 34 that showed lower levels of anxiety than 
the remaining studies. For depression, the SMD was 1.28 
(95% CI 0.47 to 2.09); again with significant heterogeneity 
(Q=154.5, df=7, p<0.0001; I2=95.47%), in this case the 
studies falling into two categories, those with lower30 34 35 and 
with higher depression scores among those isolated.19 20 33 36 
The forest plots for these outcomes are shown in figures 3 
and 4, respectively.
Studies not reporting the raw data showed that contact 
precautions were associated with depression OR 1.4 (95% 
CI 1.2 to 1.5) but not anxiety OR 0.8 (95% CI 0.7 to 1.1) 
in the non- ICU population.41 There was also an association 
with delirium OR 1.40 (95% CI 1.24 to 1.51); although this 
was primarily among those who were newly diagnosed as 
needing isolation OR 1.75 (95% CI 1.60 to 1.92, p<0.01) 
rather than those who had been under contact precautions 
for their entire stay OR 0.97 (95% CI 0.86 to 1.09, p=0.60).17 
Another study showed no difference in the median values 
for the Hospital Anxiety and Depression Scale anxiety or 
depression scores, or the EuroQol Visual Analogue Scale 
scores.42
For non- psychological outcomes, using a difference in 
the risk of ±20% of an event as being a measure of clinical 
significance it appears there was a trend for less attention 
to be given to, and for more errors to occur in those who 
were isolated. However, again there was a wide variation 
between studies. Data on these outcomes are given in 
figures 5 and 6, and the non- clinically significant risks 
in the online supplementary file 5. For those outcomes 
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Figure 3 Meta- analysis of the standardised mean difference of anxiety in those isolated versus those not isolated.
Figure 4 Meta- analysis of the standardised mean difference of depression in those isolated versus those not isolated.
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Figure 5 Risk ratio (RR) of non- psychological events in those isolated versus not isolated with an RR of ≤0.8 or ≥1.2. *Outcome 
was measured in rate per 100 admissions.
Figure 6 Standardised mean difference of non- psychological scores in those isolated versus those not isolated FIM. FIM, 
functional independence measure.
associated with quality, the median RR (with positive 
outcomes reversed so a higher RR is associated with a 
worse outcome) was 0.94 (IQR 0.92–0.98), satisfaction 
0.95 (IQR 0.89–1.01) and adverse events was 1.27 (0.91–
2.5). The minimum and maximum RR for each category 
was 0.49 and 1.72; 0.3 and 8; and 0.3 and 18, respectively.
A study not giving raw data which looked at the rates of 
falls and pressure ulcers before and after a policy change 
that resulted in the discontinuation of contact precau-
tions for patients with MRSA or vancomycin- resistant 
enterococci (VRE) found that falls and pressure ulcers 
were more common among those with MRSA or VRE 
both before the change (when they were in isolation) 
and afterwards (when they were not). Before the change, 
the number of falls was 4.57 vs 2.04 per 1000 patient- days 
respectively (p<0.0001) and pressure ulcers 4.87 vs 1.22 
per 1000 patient- days (p<0.0001). After the policy change, 
the same numbers were falls 4.82 vs 2.10 (p<0.0001) 
and pressure ulcers 4.17 vs 1.19 per 1000 patient- days 
(p<0.0001).39 Other studies found that staff spent less 
time with those on contact precautions: internal medi-
cine interns spent less time with their isolated patients 
compared with non- isolated patients, the median times 
being 5.2 and 6.9 min, respectively (p<0.001)38; while 
the mean number of contacts per hour with healthcare 
workers was 2.1 compared with 4.2 in those not isolated 
(p=0.03), although the duration was longer at 4.5 min 
compared with 2.8 (p=0.6).40
DISCuSSIOn
Current recommendations say that contact precautions 
should include a single room, with personal protective 
equipment consisting of a gown and gloves for all patient 
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contacts or contacts with potentially contaminated envi-
ronmental areas.1 This review has shown that there are a 
number of apparently negative aspects to contact precau-
tions, in particular with regard to psychological effects 
and a reduction in the quality of some aspects of care. 
These data come from studies carried out in a variety of 
countries and different types of facilities; although there 
are few data from particularly vulnerable populations 
such as the elderly.
Although at times there are discussions as to the neces-
sity of contact precautions for drug- resistant organisms, 
with some arguing that there is mixed evidence for or 
against their use49 another recent review has concluded 
that they are of great importance in the control of 
epidemic and endemic multidrug- resistant microorgan-
isms.50 The ethics of using contact precautions and other 
forms of isolation rely on a positive assessment of the 
balance between the risks and benefits of this to the indi-
vidual concerned and that of the broader population of 
patients and staff.51 However, even when this assessment 
is positive, it is important to ensure that any harm to the 
individual is minimised.
One way of balancing the various priorities is to use the 
Grading of Recommendations, Assessment,Development 
and Evaluation (GRADE) Working Group (GRADE) 
Evidence to Decision Framework, which provides criteria 
for making recommendations at the individual, group 
and policy levels, and provides a number of highly patient 
focused criteria for doing this. In addition to the certainty 
of evidence and resource requirements, it also requires 
consideration of: the balance of desirable and unde-
sirable effects; the impact on equity; and the feasibility 
and acceptability of the intervention.52 The last two of 
these might have very different outcomes when consid-
ered at the population and individual levels; and there 
is certainly evidence here that for the individual patient 
the balance of desirable and undesirable effects might be 
very different to that of the broader population.
However, within the broad population of infected or 
potentially infected patients, some groups might have 
different needs. For example a study of people isolated 
for Middle East respiratory syndrome (MERS) found that 
while access to telephones reduced anxiety and anger; 
access to email, text and internet increased these.53 This 
was not an area investigated in any depth in these studies. 
Another area where information may be lacking is that of 
age, as older people in particular might feel sadness and 
loneliness more; and gender, as qualitative data suggest 
that women in isolation were more concerned about 
precautions and transmission while men were more 
resigned, rational and tended to cope better.54
In some countries, such as the USA, single rooms have 
become the standard for new hospitals and so one might 
expect fewer adverse effects if everyone is in a single 
room, this being the norm. However, it may be that a 
single room is necessary but not sufficient for these find-
ings, and that it is the combination of a single room with 
an infection that leads to these results. Certainly it is far 
from clear that the long list of advantages claimed for 
single rooms which include reduced stress, the ability to 
deliver better care, and a lower probability of dietary or 
medication errors apply to this group of patients.55
Caring for patients in single rooms does have many 
challenges, but there is evidence that these can be miti-
gated in a general population9; however, the expanding 
literature on how this can be done in a general popula-
tion does not necessarily apply here due to the necessity 
of isolation procedures which are, by design, ‘a barrier’. 
Therefore, patients’ needs for greater social interac-
tion will need a solution quite different from that which 
might be used for a different patient population, and the 
benefit of choice about this which single rooms offer does 
not apply here.56
Although this review has quantified the extent of the 
problem, we have not been able to find solutions in the 
literature. Care might be improved through increased staff 
attention with more resources being allocated to these 
patients, although the extra cost of contact precautions 
is already considerable, one estimate being that it was an 
extra US$158.90 (95% CI US$124.90 to US$192.80) per 
patient day.57 Alternatively new ways of working might be 
developed, perhaps using technology to mitigate some of 
these problems. Technology might be particularly useful 
in reducing adverse events such as medication or clinical 
errors; although increasing satisfaction and some areas of 
quality are more likely to be achieved by increasing the 
availability of staff and other people. The extent to which 
scarce resources are allocated to this may be driven in 
part by the longevity of any negative effects; which current 
literature is not really able to clarify. To understand this, 
longituduinal studies are needed.
Study strengths and limitations
This review suggests that infectious isolation has a number 
of negative effects on patients. Because this evidence is 
comprised of cohort and case–control studies, a claim for 
a causal relationship cannot be made on this evidence, 
although the strong and consistent effects across the 
studies may increase the confidence in this relationship. 
There are some qualitative data, although more in- depth 
mixed- methods data where those reporting negative 
effects are questioned about them would strengthen the 
evidence on this. In some cases, large effect sizes were 
accompanied by very wide CIs, suggesting that studies 
were underpowered, thus studies with larger sample sizes 
would be useful. It would also be useful if there were 
more consistent methods of examining and reporting 
these data, particularly outside of the realms of depres-
sion and anxiety where the variety of methods makes 
analysis of the body of evidence difficult. We were also 
unable to assess whether these effects varied according to 
reason for isolation; or to understand if they are likely to 
be long- term or simply temporary phenomena.
Although these data suggest that there is a problem, 
there is a clear gap both in what we know about improving 
the experience of isolation and what can be done in 
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practical terms to make it more tolerable for patients 
and their families. In particular older people who may 
be most vulnerable to these negative effects were under- 
represented in these studies; and this group is likely to 
represent an increasingly large proportion of those 
isolated.
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